IFTBF

Infant Bacterial Therapeutics AB - Ordinary Shares - Class B

Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Infant Bacterial Therapeutics AB - Ordinary Shares - Class B market cap is $83.25M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Infant Bacterial Therapeutics AB - Ordinary Shares - Class B 52 week high is $8.20 as of February 25, 2026.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Infant Bacterial Therapeutics AB - Ordinary Shares - Class B 52 week low is $4.78 as of February 25, 2026.

Infant Bacterial Therapeutics AB - Ordinary Shares - Class B stock price today is $6.18.

Infant Bacterial Therapeutics AB - Ordinary Shares - Class B stock price yesterday was $5.47.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Infant Bacterial Therapeutics AB - Ordinary Shares - Class B's P/E ratio is -12.52.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Infant Bacterial Therapeutics AB - Ordinary Shares - Class B P/B ratio is 7.2864.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Infant Bacterial Therapeutics AB - Ordinary Shares - Class B 50-day moving average is $5.25.

Infant Bacterial Therapeutics AB - Ordinary Shares - Class B has 8 employees.